SR 16832 is a dual site PPARγ inhibitor that acts at orthosteric and allosteric sites in the ligand binding domain and inhibits binding of endogenous ligands and transcriptional activity of PPARγ, more effectively than the orthosteric covalent antagonists GW 9662 and T 0070907. References:

纯度：≥98%

CAS：2088135-12-8